Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jen WY"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 14, Pp 301-308 (2020)
Wei-Ying Jen,1 Joanne Yoong,2 Xin Liu,1 Melinda Si Yun Tan,3 Wee Joo Chng,1 Yen-Lin Chee1 1Department of Haematology-Oncology, National University Cancer Institute, Singapore; 2Centre for Health Services and Policy Research, Saw Swee Hock School of P
Externí odkaz:
https://doaj.org/article/837fd2504ca740258508d1921a7535c1
Autor:
Sahib NRBM; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Mohamed JS; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore., Rashid MBMA; KYAN Technologies Pte Ltd, Singapore., Jayalakshmi; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Lin YC; Department of Haematology, Tan Tock Seng Hospital, Singapore., Chee YL; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore., Fan BE; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology, Tan Tock Seng Hospital, Singapore.; Lee Kong Chain School of Medicine, Nanyang Technological University, Singapore.; Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore., De Mel S; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore., Ooi MGM; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore., Jen WY; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore.; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chow EK; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Nov; Vol. 13 (22), pp. e70401.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2229-2232. Date of Electronic Publication: 2024 Aug 28.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Electronic address: nshort@mdanderson.org.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Sep; Vol. 24 (9), pp. 565-572. Date of Electronic Publication: 2024 Mar 06.
Autor:
Marvin-Peek J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCue D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Burger J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abusab T; Department of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA., Jorgensen J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., O'Brien S; Department of Medicine, UCI Health Chao Family Comprehensive Cancer Center, Orange, CA, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1325-1334. Date of Electronic Publication: 2024 May 15.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Konopleva M; Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2024 Jul 01; Vol. 130 (13), pp. 2260-2271. Date of Electronic Publication: 2024 Apr 15.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 30-47. Date of Electronic Publication: 2024 May 09.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2259-2263. Date of Electronic Publication: 2024 Apr 11.
Autor:
Song Y; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore., Lee SY; Division of Gastroenterology & Hepatology, Department of Medicine, National University Hospital, Singapore 119074, Singapore., Chee YL; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore., Jen WY; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2024 Mar 25; Vol. 13 (7). Date of Electronic Publication: 2024 Mar 25.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rausch CR; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCue D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCue D; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 378-382. Date of Electronic Publication: 2023 Dec 06.